Literature DB >> 36244850

Acanthamoeba species from a post-covid patient with CSF rhinorrhea; a next possible post covid menace? A case report.

Archana Keche1, Sharmistha Chakravarty2, Shagufta Khatoon3, Pankaj Kannauje4, Ripu Daman Arora5.   

Abstract

A case of Acanthamoeba rhinorrhea in a 32 years female, who was recently recovered from COVID-19 infectionat a tertiary care institute in India. Though, there was no standard treatment protocol for management of amoebic-meningo encephalitis. The patient was managed successfully with combination therapy of amphotericin B and miltefosine. Agents having trophicidal and cysticidal activities are used for treatment of CNS Acanthamoeba infection. COVID 19 infection, steroid therapy anddiabetes mellitus which lead to low immunitywere found to be associated contributing factors.
Copyright © 2022 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acanthamoeba; COVID19; Rhinorrhea

Year:  2022        PMID: 36244850      PMCID: PMC9561446          DOI: 10.1016/j.ijmmb.2022.09.014

Source DB:  PubMed          Journal:  Indian J Med Microbiol        ISSN: 0255-0857            Impact factor:   1.347


Introduction

Acanthamoeba, afree-living amoebacausegranulomatous amoebic encephalitis (GAE) & keratitis is widely distributed in the environment [1,2]. Diagnosis is made by Microscopy & cultivation of protozoa [3].With the surge inthe casesof Covid associated Mucormycosis,a case of CSF rhinorrhea with fever and headache was accidently detected with acanthamoeba trophozoitesis reported in this study.

Case history

A 32-year-old female visited to ENT ward with continuous watery discharge from nostrils with on and off fever and headache forfifteen days. Discharge had no smellandnot bloody and she was unable to sniffit back. She was Covid-19 positive by RTPCR 15 days back which was managed conservatively with oxygen, remdesivir and oral deflazacort. She was recently diagnosed with diabetes mellitus. Onexamination, she was afebrile, restless and irritable with no neck stiffness and negative Kernig's and Brudzinski's signs. The rhinorrhea fluid was clear with few white fibrillar material. Protein and glucose concentration were 138.35mg/dl and 90 mg/dlrespectively and showing 100% lymphocytes. Beta trace protein (BTP) in CSF was found to be 27.8 mg/L and BTP(CSF)/BTP serum ratio was 79.43 ml/L. Serum calcium, magnesium & ferritin levels were3.4 mg/dl, 1.26 mg/dl and 248.7 respectively which were critical. Glycosylated hemoglobin (HbA1c) was 7.7%.CECT cisternography revealed a defect in right cribriform plate while brain parenchyma appeared normal. A Contrast enhanced MRI (CE-MRI) cisternography revealed a bony defect on right cribriform plate &suspected leak in left cribriform plate. On Microbiological evaluation CSF, (microscopy & culture), wet mount examination revealed many cells with amoeboid movement showing vacuolated cytoplasm, nucleus and a central nucleolus ( ​× ​1000), having a single nucleus centrally or slightly eccentricallywhich was suggestive of Acanthamoeba trophozoites (Fig. 1 A). On Gram stain few pus cells and Giemsa stain many trophozoites and few cystic forms were revealed (Fig. 1B). TheCSF sample wasinoculated innon-nutrientagar medium withoverlayed Escherichia coli suspension. Therewas evidence of trophozoites with characteristic acanthopodia (Fig. 1C). Simultaneously,a suspension of Escherichia coli was madein steriledistilled water adjusted to pH∼6.5 in which 2–3 drops of CSF was inoculated. There was no growth on bacterial & fungal culture. The patient was treated with InjectableCeftriaxone, Amphotericin Bdeoxycholate, Azithromycin&oral Miltefosine and fluconazole. The number of observed amoebae decreased with subsequent sample and the last CSF sample sent before discharge was free from amoebae.
Fig. 1

A) Trophozoite of Acanthamoeba in wet mount from culture. B) Geimsa stain of Acanthamoeba C) Wet mount examination of culture with methylene blue drop.

A) Trophozoite of Acanthamoeba in wet mount from culture. B) Geimsa stain of Acanthamoeba C) Wet mount examination of culture with methylene blue drop.

Discussion

Acanthamoeba is responsible for Central nervous system infection including meningoencephalitis, granulomatous amoebic encephalitis (GAE) and amoebic keratitis, primarily in immunocompromised and also in few immunocompetent people [4,5]. Humans usually acquire amoebic meningitis by swimming or bathing in ponds, lakes, or streams. In present case, patient might have acquired the infection through the respiratory route with a history of swimming 6 months back and current diabetic status with use of steroids might have made the patient more vulnerable for infection. In this study, CECT cisternography revealed a defect in right cribriform plate with suspected CSF leak. Hypocalemia could not corelate clinically till discharge. During & after second wave of COVID-19 there was surge in COVID associated mucormycosis cases which were presented with variable clinical signs and symptoms. Nasal sample of CSF was sent to rule out mucormycosis. Microscopy & culture were negative for Mucorales but, acanthamoeba species was accidently detected in wet mount. Hence, wet mount examination proved to be key for detection which was later confirmed with culture on non-nutrient medium with Escherichia coli. She was treated symptomatically to prevent superadded bacterial or fungal infections and simultaneously given antiparasitic agent to eliminate the free-living amoeba. she was discharged from hospital after complete disappearance of initial neurological symptoms. In case series reported by Das et al.a case was presented with recurrence of amoebic encephalitis who succumbed to illness. Rest cases responded clinically with a combination of amphotericin-B, trimethoprim-sulfamethoxazole, and rifampicin [6]. Similar case management was also describe by Siripurapu et al. [7]. Hence variable outcome may be seen with these cases. Most of the time accidental detection of Acanthamoeba was reported in clinical samples [[8], [9], [10]]. Khanna et al. reported a case which was clinically suspected extrapulmonary tuberculosis, after microbiological evaluation diagnosis was changed to Acanthamoeba meningitis and treated successfully [9].Histologically few cases of Acanthamoeba had been mistakenly diagnosed as a case of inflammatory debris and histiocytes as well as Yeast in another case [10,11]. In present study, patient might have acquired the infection through the respiratory route and comorbidity diabetes and steroid therapy had made more prone for this infection. Previous history of swimming six months could be linked with this infection. In this pandemic, SARS-CoV-2 coinfection of Aspergillus, Candida, and Klebsiella have been reported with fatal outcome [12]. Present case is coinfection of SARS-COV & Acanthamoeba. It was managed conservatively with combination therapy containing amphotericin B, miltefosine. Combination therapy with miltefosine was also proved effective in the previous reports [[13], [14], [15]]. Miltefosine is also recommended by CDC on page (Parasite – Granulomatous Amoebic Encephalitis (GAE) treatment; keratitis) This is a fatal disease can be cured if detected early & treated effectively. Wet mount examination of CSF is still an important tool to suspect & detect unusual pathogen in the era of this molecular diagnostic techniques.

Source of funding

None.

Conflicts of interest

None.

Ethics approval

Not Required.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms.

Credit author statement

Archana Keche: Conceptualization, Methodology, Software, Validation, Formal analysis, Investigation, Resources, Data Curation, Writing - Original Draft, Writing - Review & Editing, Visualization, Supervision, Project administration, Funding acquisition. Sharmistha Chakravarty: Conceptualization, Methodology, Software, Investigation, Resources, Funding acquisition, Writing - Review & Editing, Shagufta Khatoon: Conceptualization, Methodology, Software, Investigation, Resources, Funding acquisition, Writing - Review & Editing, Pankaj Kannauje: Conceptualization, Methodology, Software, Investigation, Resources, Funding acquisition, Writing - Review & Editing, Ripu Daman Arora: Conceptualization, Methodology, Software, Investigation, Resources, Funding acquisition, Writing - Review & Editing.
  15 in total

Review 1.  Free-living, amphizoic and opportunistic amebas.

Authors:  A J Martinez; G S Visvesvara
Journal:  Brain Pathol       Date:  1997-01       Impact factor: 6.508

2.  Opportunistic free: Living amoeba now becoming a usual pathogen?

Authors:  Dnyaneshwari Purushottam Ghadage; Archana Chintaman Choure; Archana Bhimrao Wankhade; Arvind Vamanrao Bhore
Journal:  Indian J Pathol Microbiol       Date:  2017 Oct-Dec       Impact factor: 0.740

3.  Granulomatous amoebic encephalitis caused by Acanthamoeba in a patient with AIDS: a challenging diagnosis.

Authors:  Hsien Lee Lau; Daniela F De Lima Corvino; Francisco M Guerra; Amer M Malik; Paola N Lichtenberger; Sakir H Gultekin; Jana M Ritter; Shantanu Roy; Ibne Karim M Ali; Jennifer R Cope; M Judith D Post; Jose A Gonzales Zamora
Journal:  Acta Clin Belg       Date:  2019-08-27       Impact factor: 1.264

4.  Disseminated Acanthamoeba infection in a human immunodeficiency virus-infected infant.

Authors:  Heidi Schwarzwald; Purvi Shah; John Hicks; Moise Levy; Milton L Wagner; Mark W Kline
Journal:  Pediatr Infect Dis J       Date:  2003-02       Impact factor: 2.129

5.  Primary amebic meningoencephalitis--Arizona, Florida, and Texas, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-05-30       Impact factor: 17.586

6.  Acanthamoeba meningoencephalitis.

Authors:  S R Chandra; Sikandar Adwani; Anitha Mahadevan
Journal:  Ann Indian Acad Neurol       Date:  2014-01       Impact factor: 1.383

7.  Successful culture of Acanthamoeba remains a key towards diagnosis of unusual clinical presentation of keratitis: A first case report from chhattisgarh.

Authors:  Archana B Wankhade; Priyadarshini Patro; Neeta Mishra; Padma Das
Journal:  J Family Med Prim Care       Date:  2021-11-05

8.  Successful treatment of disseminated Acanthamoeba sp. infection with miltefosine.

Authors:  Alexander C Aichelburg; Julia Walochnik; Ojan Assadian; Helmut Prosch; Andrea Steuer; Gedeon Perneczky; Govinda S Visvesvara; Horst Aspöck; Norbert Vetter
Journal:  Emerg Infect Dis       Date:  2008-11       Impact factor: 6.883

9.  SUCCESSFUL MANAGEMENT OF POST-COVID-19 ACANTHAMOEBIC ENCEPHALITIS.

Authors:  Govinda Siripurapu; Sameer Abdul Samad; Saman Fatima; Naveet Wig; M V Padma Srivastava
Journal:  Int J Infect Dis       Date:  2021-07-21       Impact factor: 3.623

10.  Central nervous system infection due to Acanthamoeba: A case series.

Authors:  Shukla Das; Rumpa Saha; Mayuri Rani; Ritika Goyal; Dheeraj Shah; Jhajjar K Asish
Journal:  Trop Parasitol       Date:  2016 Jan-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.